Your browser doesn't support javascript.
loading
Cu-doped TiO2 nanoparticles improve local antitumor immune activation and optimize dendritic cell vaccine strategies.
Hesemans, Evelien; Saffarzadeh, Neshat; Maksoudian, Christy; Izci, Mukaddes; Chu, Tianjiao; Rios Luci, Carla; Wang, Yuqing; Naatz, Hendrik; Thieme, Sebastian; Richter, Cornelia; Manshian, Bella B; Pokhrel, Suman; Mädler, Lutz; Soenen, Stefaan J.
Affiliation
  • Hesemans E; NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Saffarzadeh N; NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Maksoudian C; NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Izci M; NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Chu T; NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Rios Luci C; NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Wang Y; Leibniz Institute for Materials Engineering IWT, Badgasteiner Straße 3, 28359, Bremen, Germany.
  • Naatz H; Faculty of Production Engineering, University of Bremen, Badgasteiner Straße 1, 28359, Bremen, Germany.
  • Thieme S; Leibniz Institute for Materials Engineering IWT, Badgasteiner Straße 3, 28359, Bremen, Germany.
  • Richter C; Faculty of Production Engineering, University of Bremen, Badgasteiner Straße 1, 28359, Bremen, Germany.
  • Manshian BB; UniversitatsKlinikum, Dresden, Germany.
  • Pokhrel S; UniversitatsKlinikum, Dresden, Germany.
  • Mädler L; Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Soenen SJ; Leuven Cancer Institute, KU Leuven, Leuven, Belgium.
J Nanobiotechnology ; 21(1): 87, 2023 Mar 13.
Article de En | MEDLINE | ID: mdl-36915084

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / Vaccins anticancéreux / Nanoparticules / Tumeurs Limites: Animals / Humans Langue: En Journal: J Nanobiotechnology Année: 2023 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / Vaccins anticancéreux / Nanoparticules / Tumeurs Limites: Animals / Humans Langue: En Journal: J Nanobiotechnology Année: 2023 Type de document: Article Pays d'affiliation: Belgique Pays de publication: Royaume-Uni